Back Stocks profile

Stock analysis tool for investors

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE:500124

₹6193.55 -230.70 (-3.59%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

6172.10

Today’s High

6473.00

52W low

4309.00

52W High

6505.90

Open Price

6449.00

Prev. Close

6424.2500

Volume

592285.00

Value

3668346761.75

Fundamentals

Market Cap Cr

103316.60

Price to Earnings

19.80

Price to Book Value

4.40

Dividend Yield

0.60

PE to Growth

0.50

Op Revenue TTM Cr

27212.50

Net Profit TTM Cr

5228.20

Cash From Operating Activity Cr

5887.50

Return on Equity %

19.35

EMA & SMA

Bullish Moving Averages

8

Bearish Moving Averages

8

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

01 Mar, 2024

34.1

Week

55.5

Month

51

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

6279.55

PIVOT

First Resistance

6387.00

Second Resistance

6580.45

Third Resistance

6687.90

First Support

6086.10

Second Support

5978.65

Third Support

5785.20

Relative Strength Index

48.49

Money Flow Index

36.27

MACD

115.18

MACD Signal

137.64

Average True Range

135.19

Average Directional Index

29.41

Rate of Change (21)

3.34

Rate of Change (125)

10.44

Commodity Channel Index

-18.2

Williams %R

-93

BETA

1 Month

-0.6

3 Month

0.25

1 Year

0.21

3 Year

0.01

PRICE CHANGE ANALYSIS

-3.86%

1 Week

Low

High

6172.1

6505.9

3.34%

1 Month

Low

High

5991.1

6505.9

7.73%

3 Months

Low

High

5370

6505.9

11.02%

6 Months

Low

High

5205.55

6505.9

42.57%

1 Year

Low

High

4309

6505.9

01 Mar 2024

Dr Reddy's Stock Slips 4% After Being Named In U.S. Anti-Trust Lawsuit

The company said that it believes that allegations against it lack merit and will vigorously defend the litigation.
Bigul
01 Mar 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Bigul
28 Feb 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of The SEBI LODR Regulations, 2015

Disclosure under Regulation 30 of the SEBI Listing Regulations, 2015
Bigul
22 Feb 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of equity shares on exercise of stock options under Employee Stock Options Scheme
22 Feb 2024

Dr. Reddy's Labs - U.S., Europe To Drive Growth: Nirmal Bang

The US market has demonstrated growth in both base business as well as limited volume launches such as Lenalidomide (Revlimid).
Bigul
21 Feb 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI LODR

Disclosure under Regulation 30 of SEBI LODR
See all News

FAQs

The latest market price of Dr. Reddy's Laboratories Ltd. on NSE was Rs. 6193.55 as of today.

The opening share price of Dr. Reddy's Laboratories Ltd. was Rs. 6449.00 as of today.

The 52-week high share price of Dr. Reddy's Laboratories Ltd. was Rs. 6505.90.

The 52 week low share price of Dr. Reddy's Laboratories Ltd. was Rs. 4309.00.

Dr. Reddy's Laboratories Ltd. has a market cap of Rs. 103316.60 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Dr. Reddy's Laboratories Ltd. is 0.50. Please refer to the Fundamentals section for further details.

The operating revenue for Dr. Reddy's Laboratories Ltd. in the last FY was Rs.  27212.50 crore. Please refer to the Financials section for further details.

The Net Profit for Dr. Reddy's Laboratories Ltd. in the last FY was Rs. 5228.20 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Dr. Reddy's Laboratories Ltd. was on 2023-07-11 for Rs. 40 per share. According to today’s share price, the dividend yield of Dr. Reddy's Laboratories Ltd. stands at 0.60. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Dr. Reddy's Laboratories Ltd. was as of 2006-08-28. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Dr. Reddy's Laboratories Ltd. was as of 2001-10-10. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Dr. Reddy's Laboratories Ltd..